Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

American Journal of Cardiology - Tập 93 - Trang 780-782 - 2004
Arnljot Tveit1, Morten Grundtvig2, Torstein Gundersen3, Paul Vanberg4, Anne Grete Semb5, Even Holt1, Lars Gullestad1
1Department of Internal Medicine, Asker & Baerum Hospital, Rud, Norway
2Department of Internal Medicine, Innlandet Lillehammer Hospital, Lillehammer, Norway
3Department of Internal Medicine, Sorlandet Hospital, Arendal, Norway
4Department of Internal Medicine, Aker University Hospital, Oslo, Norway
5Department of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway

Tài liệu tham khảo

Holm, 2001, Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients, Am J Cardiol, 87, 815, 10.1016/S0002-9149(00)01516-2 Laufs, 2000, Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription, Circulation, 102, 3104, 10.1161/01.CIR.102.25.3104 Lefer, 2002, Statins as potent antiinflammatory drugs, Circulation, 106, 2041, 10.1161/01.CIR.0000033635.42612.88 Albert, 2001, Effect of statin therapy on C-reactive protein levels, JAMA, 286, 64, 10.1001/jama.286.1.64 Mitchell, 2003, Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, J Am Coll Cardiol, 42, 81, 10.1016/S0735-1097(03)00498-4 Anderson, 2003, Lipid-lowering therapy for prevention of ventricular tachyarrhythmias, J Am Coll Cardiol, 42, 88, 10.1016/S0735-1097(03)00497-2 Young-Xu, 2003, Statins reduce the incidence of atrial fibrillation in patients with coronary artery disease, J Am Coll Cardiol, 41, 301A, 10.1016/S0735-1097(03)82411-7 Dernellis, 2001, C-reactive protein and paroxysmal atrial fibrillation, Acta Cardiol, 56, 375, 10.2143/AC.56.6.2005701 Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmias, Circulation, 104, 2886, 10.1161/hc4901.101760 Takahashi, 2001, Atrial fibrillation impairs endothelial function of forearm vessels in humans, J Card Fail, 7, 45, 10.1054/jcaf.2001.22107 Conway, 2002, Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation, Circulation, 106, 1962, 10.1161/01.CIR.0000033220.97592.9A Cai, 2002, Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation, Circulation, 106, 2854, 10.1161/01.CIR.0000039327.11661.16